Anti-inflammatory genes in PBMCs post-spontaneous intracerebral hemorrhage

• Published in: Translational neuroscience Vol. 12; no. 1; pp. 58 - 66
• Main Authors: Nguyen, Doan, Tran, Vi, Shirazian, Alireza, Velasco-Gonzalez, Cruz, Iwuchukwu, Ifeanyi
• Format: Journal Article
• Language: English
• Published: Germany De Gruyter 01.01.2021; De Gruyter Poland
• Subjects: Blood; clinical outcome; Gene expression; Glyceraldehyde-3-phosphate dehydrogenase; Hematoma; Hemorrhage; Inflammation; Interleukin 1; Interleukin 10; intracerebral hemorrhage; Leukocytes (mononuclear); Patients; Peripheral blood mononuclear cells; Peroxisome proliferator-activated receptors; Statistical analysis; Statistical methods; Superoxide dismutase; intracerebral hemorrhage; peripheral blood mononuclear cells; clinical outcome; gene expression
• ISSN: 2081-3856; 2081-6936; 2081-6936
• DOI: 10.1515/tnsci-2021-0003

Neuroinflammation is important in the pathophysiology of spontaneous intracerebral hemorrhage (ICH) and peripheral inflammatory cells play a role in the clinical evolution and outcome. Blood samples from ICH patients ( = 20) were collected at admission for 5 consecutive days for peripheral blood mononuclear cells (PBMCs). Frozen PBMCs were used for real-time PCR using Taqman probes (NFKB1, SOD1, PPARG, IL10, NFE2L2, and REL) and normalized to GAPDH. Data on hospital length of stay and modified Rankin score (MRS) were collected with 90-day MRS ≤ 3 as favorable outcome. Statistical analysis of clinical characteristics to temporal gene expression from early to delayed timepoints was compared for MRS groups (favorable vs unfavorable) and hematoma volume. IL10, SOD1, and REL expression were significantly higher at delayed timepoints in PBMCs of ICH patients with favorable outcome. PPARG and REL increased between timepoints in patients with favorable outcome. NFKB1 expression was not sustained, but significantly decreased from higher levels at early onset in patients with unfavorable outcome. IL10 expression showed a negative correlation in patients with high hematoma volume (>30 mL). Anti-inflammatory, pro-survival regulators were highly expressed at delayed time points in ICH patients with a favorable outcome, and IL10 expression showed a negative correlation to high hematoma volume.